Regulatory News

Topics also related to Regulatory News Sections:

UPDATE 1-U.S. FDA moves to ban sales of e-cigarettes to minors

(Adds reaction from public health advocates; e-cig company)

8:21am BST

European shares bounce; Alstom jumps on M&A talk

PARIS, April 24 - European shares rose in early trade on Thursday, recouping most of the previous session's losses, with Alstom surging on merger and acquisition talk.

Minister warns foreign firms against leaving Russia over sanctions

MOSCOW, April 24 - Russia's Natural Resources Minister said on Thursday that the door would be closed to foreign companies working in Russia if they decide to leave the country over Ukraine-related sanctions.

8:06am BST

BRIEF-Dialog Semiconductor rises on strong iPhone sales

FRANKFURT, April 24 - Shares in Dialog Semiconductor rise 3.5 percent at open after Apple Inc reports better than expected iphone sales

8:05am BST

UPDATE 1-AstraZeneca flags cancer advances, silent on Pfizer bid talk

LONDON, April 24 - AstraZeneca highlighted progress with new cancer drugs that may revive its fortunes as it posted a 17 percent fall in core earnings per share on Thursday, reflecting patent losses on profitable older medicines.

German stocks - Factors to watch on April 24

FRANKFURT, April 24 - The DAX top-30 index looked set to open 0.5 percent higher on Thursday, according to premarket data from brokerage Lang & Schwarz at 0640 GMT.

7:43am BST

UK Stocks-Factors to watch on April 24

LONDON, April 24 - Britain's FTSE 100 index is seen opening 18 to 19 points higher on Thursday, or as much as 0.3 percent stronger, according to financial bookmakers. For more on the factors affecting European stocks, please click on

Europe Factors to Watch-Shares set to bounce; eyes on earnings

PARIS, April 24 - European stocks were seen rising on Thursday, reversing most of the previous session's losses as strong results from U.S. companies Apple and Facebook helped boost sentiment. Gains could be limited, however, as the damage of currency effects on European earnings was showing up in quarterly results of a number of companies including Unilever , Suez Environnement and Schneider Electric. A stronger euro hit Suez, who said the negative exchange rate impact on quar

AstraZeneca flags cancer advances, silent on Pfizer bid talk

LONDON, April 24 - AstraZeneca highlighted progress with a new generation of cancer drugs that may revive its fortunes as it posted a 17 percent fall in core earnings per share on Thursday, reflecting patent losses on profitable older medicines.